News
-
Medical Research Agency as the winner of Portraits of Polish Medicine 2020
Medical Research Agency has received the "Portraits of Polish Medicine" award in the category Event of the Year!
-
Medical Research Agency with the award "Innovators Wprost 2020"!
On Wednesday, 30 September, the 10th jubilee gala of "Wprost Innovators" awards was held, during which innovative products and companies as well as exceptional people were awarded for their contribution to the development of Polish science, technology and technology.
-
Results of the call or research and development activities in the field of non-commercial clinical trials - 1st round
President of the Medical Research Agency Radosław Sierpiński, MD PhD approved the ranking list containing the results of the competition for research and development activities in the field of non-commercial clinical trials in the first round of the competition.
-
Establishment of the first network of centres conducting clinical research in Poland
The Medical Research Agency allocated PLN 100 million to create a network of ten specialised Clinical Research Support Centres. The newly established Centres will allow for better coordination of clinical trials in Poland
-
Children with lymphoblastic leukemia with a chance to be cured
Over 1100 children in Poland suffer from cancer every year. Acute lymphoblastic leukemia (ALL) is the most common malignant tumor in this group. Thanks to the financing of the Medical Research Agency, the Medical University of Lodz has started a research project CALL-POL, which will cover all children in Poland with newly diagnosed ALL.
-
MRA will donate 100 million for cancer treatment with a breakthrough CAR-T cells
The Medical Research Agency is launching a programme aimed at developing and introducing to Poland on a large scale a breakthrough cancer treatment using genetically modified CAR-T cells (adoptive therapy with CART cells). This type of therapy is particularly important in the treatment of leukaemia in the youngest patients. CAR-T cell technology changes the perspective of oncological treatment.
-
Medical Research Agency will allocate 100 million for the creation of specialized Clinical Research Support Centres.
The initiative aims to increase the number of both clinical trials and their participants in Poland, as well as to use the potential of the clinical trials sector to increase the competitiveness of the national economy.
-
The Medical Research Agency will allocate PLN 50 million to fight the coronavirus.
The Medical Research Agency and the Ministry of Health have decided to allocate at least PLN 50 million to support non-commercial clinical trials aimed at preventing COVID-19.
-
Medical Research Agency allocated measures for designing the vaccine, therapy and development of fast diagnostic tests techniques.
Due to numerous questions from potential applicants we have clarified and expanded the rules governing fast implementation of COVID-19 projects.
-
POLCRIN - international support for non-commercial clinical research
In connection with Poland's accession to the European Clinical Research Infrastructure Network (ECRIN) on 23 August 2019 for a period of three years in the role of an observer, the Medical Research Agency has created the POLCRIN entity (Eng. Polish Clinical Research Infrastructure Network).